Literature DB >> 21712728

Health coverage and its relation to the prevalence and intensity of symptomatic knee osteoarthritis.

Jacob Clearfield1, Neil A Segal.   

Abstract

OBJECTIVE: This study aimed to determine whether health coverage among older adults is associated with (1) the prevalence of symptomatic knee osteoarthritis (OA) and (2) disablement in those with symptomatic knee OA.
METHODS: Data were collected from the Osteoarthritis Initiative data set 5.2.1, a cohort study of subjects with or at risk for knee OA. Prevalence of symptomatic knee OA (knee symptoms on most of the last 30 days and Kellgren-Lawrence grade >2 on knee radiograph) was compared between those with and without health coverage among subjects aged 45 to 65 years, adjusted for age and body mass index. For those with symptomatic knee OA, Physical Activity for the Elderly scores and Knee Osteoarthritis Outcomes Survey function, pain, and quality-of-life scores were compared between those with and without health coverage before and after adjustment for age and body mass index.
RESULTS: Among subjects with health coverage, 27.8% had symptomatic knee OA compared with 36.1% of those without health coverage (P = 0.0204 before and P > 0.24 after adjustment). Among subjects with symptomatic knee OA with and without health coverage physical activity differed significantly (P = 0.048), as did pain (P < 0.0001), function (P = 0.0001), and quality of life (P < 0.0001).
CONCLUSIONS: Lack of health coverage was not associated with the prevalence of symptomatic knee OA after adjustment. However, those with symptomatic knee OA without health coverage reported reduced physical activity, greater pain, worse functional limitations, and decreased quality of life.

Entities:  

Mesh:

Year:  2011        PMID: 21712728      PMCID: PMC3196827          DOI: 10.2310/JIM.0b013e318224d8b8

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  23 in total

Review 1.  Radiographic criteria for classification of osteoarthritis.

Authors:  C J Menkes
Journal:  J Rheumatol Suppl       Date:  1991-02

2.  Assessing depressive symptoms in five psychiatric populations: a validation study.

Authors:  M M Weissman; D Sholomskas; M Pottenger; B A Prusoff; B Z Locke
Journal:  Am J Epidemiol       Date:  1977-09       Impact factor: 4.897

Review 3.  Economics of osteoarthritis: a global perspective.

Authors:  L M March; C J Bachmeier
Journal:  Baillieres Clin Rheumatol       Date:  1997-11

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 5.  Epidemiology of osteoarthritis.

Authors:  M A Davis
Journal:  Clin Geriatr Med       Date:  1988-05       Impact factor: 3.076

6.  The Physical Activity Scale for the Elderly (PASE): development and evaluation.

Authors:  R A Washburn; K W Smith; A M Jette; C A Janney
Journal:  J Clin Epidemiol       Date:  1993-02       Impact factor: 6.437

7.  Impact of Medicare coverage on basic clinical services for previously uninsured adults.

Authors:  J Michael McWilliams; Alan M Zaslavsky; Ellen Meara; John Z Ayanian
Journal:  JAMA       Date:  2003-08-13       Impact factor: 56.272

8.  Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure.

Authors:  E M Roos; H P Roos; L S Lohmander; C Ekdahl; B D Beynnon
Journal:  J Orthop Sports Phys Ther       Date:  1998-08       Impact factor: 4.751

9.  The effects of specific medical conditions on the functional limitations of elders in the Framingham Study.

Authors:  A A Guccione; D T Felson; J J Anderson; J M Anthony; Y Zhang; P W Wilson; M Kelly-Hayes; P A Wolf; B E Kreger; W B Kannel
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

10.  Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial.

Authors:  Elizabeth H B Lin; Wayne Katon; Michael Von Korff; Lingqi Tang; John W Williams; Kurt Kroenke; Enid Hunkeler; Linda Harpole; Mark Hegel; Patricia Arean; Marc Hoffing; Richard Della Penna; Chris Langston; Jürgen Unützer
Journal:  JAMA       Date:  2003-11-12       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.